Neurological Biomarkers Market Size, Share & Trends Report

Neurological Biomarkers Market Size, Share & Trends Analysis Report By Application (Alzheimer’s, Parkinson’s, Multiple Sclerosis, Autism), By Type, By End-use, By Region, And Segment Forecasts, 2024 - 2030

Report ID: GVR-3-68038-823-7
Number of Pages: 120
Format: Electronic (PDF)

Historical Range: 2018 - 2022
Industry: Healthcare

Market Segmentation

Neurological Biomarkers Type Outlook (Revenue, USD Million, 2018 - 2030)
- Genomic
- Proteomic
- Metabolomic
- Imaging
- Others
Neurological Biomarkers Application Outlook (Revenue, USD Million, 2018 - 2030)
- Alzheimer's Disease
- Parkinson's Disease
- Multiple Sclerosis
- Autism Spectrum Disorder
- Others
Neurological Biomarkers End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital & Hospital Laboratories
- Independent clinical diagnostic centers
- Research Organizations and Others
Neurological Biomarkers Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Neurological Biomarkers Market, Type Outlook
    - Genomic
    - Proteomic
    - Metabolomic
    - Imaging
    - Others
  - North America Neurological Biomarkers Market, Application Outlook
    - Alzheimer's Disease
    - Parkinson's Disease
    - Multiple Sclerosis
    - Autism Spectrum Disorder
    - Others
  - North America Neurological Biomarkers Market, End-Use Outlook
    - Hospital & Hospital Laboratories
    - Independent clinical diagnostic centers
    - Research Organizations and Others
  - U.S.
    - U.S. Neurological Biomarkers Market, Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - U.S. Neurological Biomarkers Market, Application Outlook
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - U.S. Neurological Biomarkers Market, End-Use Outlook
      - Hospital & Hospital Laboratories
      - Independent clinical diagnostic centers
      - Research Organizations and Others
  - Canada
    - Canada Neurological Biomarkers Market, Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Canada Neurological Biomarkers Market, Application Outlook
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Canada Neurological Biomarkers Market, End-Use Outlook
      - Hospital & Hospital Laboratories
      - Independent clinical diagnostic centers
      - Research Organizations and Others
- Europe
  - Europe Neurological Biomarkers Market, Type Outlook
    - Genomic
    - Proteomic
    - Metabolomic
    - Imaging
    - Others
  - Europe Neurological Biomarkers Market, Application Outlook
    - Alzheimer's Disease
    - Parkinson's Disease
    - Multiple Sclerosis
    - Autism Spectrum Disorder
    - Others
  - Europe Neurological Biomarkers Market, End-Use Outlook
    - Hospital & Hospital Laboratories
    - Independent clinical diagnostic centers
    - Research Organizations and Others
  - UK
    - UK Neurological Biomarkers Market, Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - UK Neurological Biomarkers Market, Application Outlook
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - UK Neurological Biomarkers Market, End-Use Outlook
      - Hospital & Hospital Laboratories
      - Independent clinical diagnostic centers
      - Research Organizations and Others
  - Germany
    - Germany Neurological Biomarkers Market, Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Germany Neurological Biomarkers Market, Application Outlook
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Germany Neurological Biomarkers Market, End-Use Outlook
      - Hospital & Hospital Laboratories
      - Independent clinical diagnostic centers
      - Research Organizations and Others
  - France
    - France Neurological Biomarkers Market, Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - France Neurological Biomarkers Market, Application Outlook
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - France Neurological Biomarkers Market, End-Use Outlook
      - Hospital & Hospital Laboratories
      - Independent clinical diagnostic centers
      - Research Organizations and Others
  - Spain
    - Spain Neurological Biomarkers Market, Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Spain Neurological Biomarkers Market, Application Outlook
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Spain Neurological Biomarkers Market, End-Use Outlook
      - Hospital & Hospital Laboratories
      - Independent clinical diagnostic centers
      - Research Organizations and Others
  - Italy
    - Italy Neurological Biomarkers Market, Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Italy Neurological Biomarkers Market, Application Outlook
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Italy Neurological Biomarkers Market, End-Use Outlook
      - Hospital & Hospital Laboratories
      - Independent clinical diagnostic centers
      - Research Organizations and Others
  - Denmark
    - Denmark Neurological Biomarkers Market, Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Denmark Neurological Biomarkers Market, Application Outlook
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Denmark Neurological Biomarkers Market, End-Use Outlook
      - Hospital & Hospital Laboratories
      - Independent clinical diagnostic centers
      - Research Organizations and Others
  - Sweden
    - Sweden Neurological Biomarkers Market, Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Sweden Neurological Biomarkers Market, Application Outlook
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Sweden Neurological Biomarkers Market, End-Use Outlook
      - Hospital & Hospital Laboratories
      - Independent clinical diagnostic centers
      - Research Organizations and Others
  - Norway
    - Norway Neurological Biomarkers Market, Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Norway Neurological Biomarkers Market, Application Outlook
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Norway Neurological Biomarkers Market, End-Use Outlook
      - Hospital & Hospital Laboratories
      - Independent clinical diagnostic centers
      - Research Organizations and Others
- Asia Pacific
  - Asia Pacific Neurological Biomarkers Market, Type Outlook
    - Genomic
    - Proteomic
    - Metabolomic
    - Imaging
    - Others
  - Asia Pacific Neurological Biomarkers Market, Application Outlook
    - Alzheimer's Disease
    - Parkinson's Disease
    - Multiple Sclerosis
    - Autism Spectrum Disorder
    - Others
  - Asia Pacific Neurological Biomarkers Market, End-Use Outlook
    - Hospital & Hospital Laboratories
    - Independent clinical diagnostic centers
    - Research Organizations and Others
  - Japan
    - Japan Neurological Biomarkers Market, Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Japan Neurological Biomarkers Market, Application Outlook
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Japan Neurological Biomarkers Market, End-Use Outlook
      - Hospital & Hospital Laboratories
      - Independent clinical diagnostic centers
      - Research Organizations and Others
  - China
    - China Neurological Biomarkers Market, Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - China Neurological Biomarkers Market, Application Outlook
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - China Neurological Biomarkers Market, End-Use Outlook
      - Hospital & Hospital Laboratories
      - Independent clinical diagnostic centers
      - Research Organizations and Others
  - India
    - India Neurological Biomarkers Market, Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - India Neurological Biomarkers Market, Application Outlook
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - India Neurological Biomarkers Market, End-Use Outlook
      - Hospital & Hospital Laboratories
      - Independent clinical diagnostic centers
      - Research Organizations and Others
  - South Korea
    - South Korea Neurological Biomarkers Market, Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - South Korea Neurological Biomarkers Market, Application Outlook
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - South Korea Neurological Biomarkers Market, End-Use Outlook
      - Hospital & Hospital Laboratories
      - Independent clinical diagnostic centers
      - Research Organizations and Others
  - Australia
    - Australia Neurological Biomarkers Market, Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Australia Neurological Biomarkers Market, Application Outlook
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Australia Neurological Biomarkers Market, End-Use Outlook
      - Hospital & Hospital Laboratories
      - Independent clinical diagnostic centers
      - Research Organizations and Others
  - Thailand
    - Thailand Neurological Biomarkers Market, Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Thailand Neurological Biomarkers Market, Application Outlook
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Thailand Neurological Biomarkers Market, End-Use Outlook
      - Hospital & Hospital Laboratories
      - Independent clinical diagnostic centers
      - Research Organizations and Others
- Latin America
  - Latin America Neurological Biomarkers Market, Type Outlook
    - Genomic
    - Proteomic
    - Metabolomic
    - Imaging
    - Others
  - Latin America Neurological Biomarkers Market, Application Outlook
    - Alzheimer's Disease
    - Parkinson's Disease
    - Multiple Sclerosis
    - Autism Spectrum Disorder
    - Others
  - Latin America Neurological Biomarkers Market, End-Use Outlook
    - Hospital & Hospital Laboratories
    - Independent clinical diagnostic centers
    - Research Organizations and Others
  - Brazil
    - Brazil Neurological Biomarkers Market, Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Brazil Neurological Biomarkers Market, Application Outlook
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Brazil Neurological Biomarkers Market, End-Use Outlook
      - Hospital & Hospital Laboratories
      - Independent clinical diagnostic centers
      - Research Organizations and Others
  - Mexico
    - Mexico Neurological Biomarkers Market, Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Mexico Neurological Biomarkers Market, Application Outlook
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Mexico Neurological Biomarkers Market, End-Use Outlook
      - Hospital & Hospital Laboratories
      - Independent clinical diagnostic centers
      - Research Organizations and Others
  - Argentina
    - Argentina Neurological Biomarkers Market, Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Argentina Neurological Biomarkers Market, Application Outlook
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Argentina Neurological Biomarkers Market, End-Use Outlook
      - Hospital & Hospital Laboratories
      - Independent clinical diagnostic centers
      - Research Organizations and Others
- Middle East & Africa
  - Middle East & Africa Neurological Biomarkers Market, Type Outlook
    - Genomic
    - Proteomic
    - Metabolomic
    - Imaging
    - Others
  - Middle East & Africa Neurological Biomarkers Market, Application Outlook
    - Alzheimer's Disease
    - Parkinson's Disease
    - Multiple Sclerosis
    - Autism Spectrum Disorder
    - Others
  - Middle East & Africa Neurological Biomarkers Market, End-Use Outlook
    - Hospital & Hospital Laboratories
    - Independent clinical diagnostic centers
    - Research Organizations and Others
  - South Africa
    - South Africa Neurological Biomarkers Market, Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - South Africa Neurological Biomarkers Market, Application Outlook
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - South Africa Neurological Biomarkers Market, End-Use Outlook
      - Hospital & Hospital Laboratories
      - Independent clinical diagnostic centers
      - Research Organizations and Others
  - Saudi Arabia
    - Saudi Arabia Neurological Biomarkers Market, Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Saudi Arabia Neurological Biomarkers Market, Application Outlook
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Saudi Arabia Neurological Biomarkers Market, End-Use Outlook
      - Hospital & Hospital Laboratories
      - Independent clinical diagnostic centers
      - Research Organizations and Others
  - UAE
    - UAE Neurological Biomarkers Market, Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - UAE Neurological Biomarkers Market, Application Outlook
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - UAE Neurological Biomarkers Market, End-Use Outlook
      - Hospital & Hospital Laboratories
      - Independent clinical diagnostic centers
      - Research Organizations and Others
  - Kuwait
    - Kuwait Neurological Biomarkers Market, Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Kuwait Neurological Biomarkers Market, Application Outlook
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Kuwait Neurological Biomarkers Market, End-Use Outlook
      - Hospital & Hospital Laboratories
      - Independent clinical diagnostic centers
      - Research Organizations and Others

Neurological Biomarkers Market Dynamics

Driver: Increasing Prevalence Of Neurological Diseases

Rising prevalence of neurological disorders such as Alzheimer's Disease (AD), Parkinson's disease, dementia, epilepsy, brain tumors, and others is anticipated to boost the market growth. According to Alzheimer's Association, approximately 55 million individuals globally have dementia, which is anticipated to rise to 98 million by 2030 and around 139 million by 2050. AD is a global epidemic approximately 6.5 million individuals in the U.S, will be living with AD in 2022. The prevalence of AD is higher in developing countries than in developed countries. Increasing awareness about this disease is needed for facilitating early diagnosis and timely treatment. In recent years, various research activities have been initiated for ALS treatment and diagnose. Therefore, growing number of neurological diseases globally is anticipated to fuel market growth.

Driver: Technological Advancements

Rapid technological advancements and huge demand for advanced technologies in the healthcare sector is projected to propel market growth. Increasing digitalization is anticipated to improve the management of neurological disorders, which, in turn, is expected to propel market growth during the forecast period. the development and introduction of BBBM tests for the diagnosis of indications such as AD & mild traumatic brain injury, among others, are contributing to market growth. Moreover, technological advancements in the industry continue to demonstrate the importance of highly sensitive plasma-based biomarker measurements, including Simoa pTau-181, pTau-231, and pTau-217, in AD clinical research.

Restraint: Lack Of Consumer Awareness And Dearth Of Neurologists

Lack of awareness about such diagnostic products & their high cost and limited availability or absence of neurologists, especially in developing & underdeveloped countries, could affect the adoption of such biomarker-based diagnostic solutions.

What Does This Report Include?

This section will provide insights into the contents included in this neurological biomarkers market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Neurological biomarkers market qualitative analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Neurological biomarkers market quantitative analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.